The assistant said in embarrassment: “Mr., I don’t know about this. The other party hung up the phone without letting me ask carefully…”

“What a bastard!” Jiro Kobayashi said with a black face, “If this is the case, then I can only think of a solution on this Oracle Pharmaceutical. In any case, I have to buy their formula patent!”

The assistant asked carefully: “Mr. Kobayashi, is this medicine effective?”

“Very good…” Jiro Kobayashi said gloomily, “At least ten times the effect of Kobayashi’s Niranex!”

The assistant seemed to be struck by lightning: “Ten times?! The difference is so big?!”

and said with a gloomy expression: “You must not tell this story. If we can get the prescription for Nova Dias, we can reverse everything and even take it to the next level. But if we can’t get the prescription, Kobayashi Pharmaceutical’s trouble

good prescription is a cash cow for everyone. Will this Oracle Pharmaceutical agree

gritted his teeth and said: “It’s about the life and death of our Kobayashi Pharmaceutical Co., Ltd.! Regardless of whether they agree or not,

fallen into the same madness

and wanted to use the magical medicine to cure the paralysis of his father, Masao Kobayashi, and even let Kobayashi Pharmaceutical stand up to the top of the global

unknowingly, opened the door to the same

got the results of the

“Chairman, I have found some information about Oracle Pharmaceutical. It turned out that this company was called Weaver Pharmaceutical. When we evaluated Chinese pharmaceutical companies before, we also evaluated this company. The overall market value at that time At around two

and asked, “Then it’s so good, why should it be renamed Oracle

has also changed. Before the Weaver family held 100% of the shares, but after the change, the Weaver family only held 20% of the shares. , The remaining 80% are held

“Can’t

key information of major shareholders. It is impossible to find out who owns the 80% of the shares, the president, I think

The Novel will be updated daily. Come back and continue reading tomorrow, everyone!

Comments ()

0/255